• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Kura Oncology, Inc. - Common Stock (NQ:KURA)

    9.865 -0.265 (-2.62%)
    Streaming Delayed Price Updated: 3:53 PM EDT, Oct 17, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Kura Oncology, Inc. - Common Stock

    < Previous 1 2 3 4 5 Next >
    Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data
    Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant... 
    Via MarketMinute
    10 Health Care Stocks With Whale Alerts In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
     
    Via Benzinga
    Earnings Scheduled For August 7, 2025
     
    Via Benzinga
    Earnings Scheduled For May 1, 2025
     
    Via Benzinga
    Uncovering Potential: Kura Oncology's Earnings Preview
     
    Via Benzinga
    Earnings Scheduled For February 26, 2025
     
    Via Benzinga
    2 Incredible Growth Stocks to Buy Hand Over Fist
    These two healthcare growth stocks could have a lot more room to run. 
    Via The Motley Fool
    Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth
    Syndax shares gained support after Guggenheim issued a Buy rating, citing strong Q2 results, Revuforj growth, and long-term profit potential. 
    Via Benzinga
    This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
     
    Via Benzinga
    Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday
     
    Via Benzinga
    Kura (KURA) Revenue Drops 61%
    Via The Motley Fool
    Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6
    Via Investor Brand Network
    Kura Oncology: Q4 Earnings Insights
     
    Via Benzinga
    Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
     
    Via Benzinga
    Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
    Via Stocktwits
    Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies
    Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA submission set for Q2 2025. 
    Via Benzinga
    These stocks are moving in today's after hours session
    After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
     
    Via Benzinga
    Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings
     
    Via Benzinga
    Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
     
    Via Benzinga
    Topics Stocks
    Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
    Instead of seeking a takeover, the company inked a deal worth up to $1.53 billion for its lead asset. 
    Via Investor's Business Daily
    Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
     
    Via Benzinga
    This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
     
    Via Benzinga
    KURA Stock Earnings: Kura Oncology Beats EPS for Q2 2024
    KURA stock results show that Kura Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
    Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position. 
    Via InvestorPlace
    Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
    EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
    From FN Media Group LLC
    Via GlobeNewswire
    KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024
    KURA stock results show that Kura Oncology missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.